JPRN-UMIN000008651尚未招募未知
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets - SPECIALIST registry
The PCI Guideline Research Society0 个研究点目标入组 800 人开始时间: 2012年8月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Hypersensitivity to cobalt chromium, everolimus, heparin, aspirin, ticlopidine, clopidogrel or X-ray contrast media. 2) Serum creatinine level >3.0 mg/dL 3) Other concomitant disease or medical condition that could impact patient/procedural outcomes, such as history of bleeding diathesis or cancer within 5 years.
研究者
相似试验
招募中
不适用
Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis)Complex coronary artery diseaseJPRN-UMIN000021122The PCI Guideline Research Society50
已完成
4 期
PE-Prove Study PROMUS* Element* Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study A prospective, open label, multi-center observational studyNL-OMON34092Boston Scientific International S.A.90
Unknown
不适用
Study Examining the PROMUS Element Everolimus-eluting Stent in Multi-center Coronary Intervention of Complex Arterial Lesion SubsetsCoronary Artery DiseaseNCT01670318The PCI Guideline Research Society800
已完成
3 期
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions (PLATINUM LL)Coronary Artery DiseaseNCT01500434Boston Scientific Corporation102
已完成
不适用
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small VesselsCoronary Artery DiseaseNCT01498692Boston Scientific Corporation94